Haploinsufficiency Interactions between RALBP1 and p53 in ERBB2 and PyVT Models of Mouse Mammary Carcinogenesis

• Published in: Cancers 2021-07, Vol.13 (13), p.3329
• Main Authors: Singh, Sharda P, Lee, Jihyun, Bose, Chhanda, Li, Hongzhi, Yuan, Yate-Ching, Hindle, Ashly, Singhal, Sharad S, Kopel, Jonathan, Palade, Philip T, Jones, Catherine, Rahman, Rakhshanda L, Awasthi, Sanjay
• Format: Article
• Language: English
• Subjects: Alleles; Angiogenesis; Animal models; Antigens; Apoptosis; Breast cancer; Cancer therapies; Carcinogenesis; Chemotherapy; CRISPR; Cytomegalovirus; Epidermal growth factor; Epigenetics; ErbB-2 protein; Genes; Genetic engineering; Haploinsufficiency; Kinases; Medical research; Metastases; Metastasis; Mutation; p53 Protein; Patients; Radiation; Reagents; Rodents; Transgenic animals; Transgenic mice; Tumor suppressor genes; Tumorigenesis; Tumors
• ISSN: 2072-6694; 2072-6694
• DOI: 10.3390/cancers13133329

We recently reported that loss of one or both alleles of , which encodes the stress-protective protein RLIP76 (Rlip), exerts a strong dominant negative effect on both the inherent cancer susceptibility and the chemically inducible cancer susceptibility of mice lacking one or both alleles of the tumor suppressor p53. In this paper, we examined whether congenital Rlip deficiency could prevent genetically-driven breast cancer in two transgenic mouse models: the MMTV-PyVT model, which expresses the polyomavirus middle T antigen (PyVT) under control of the mouse mammary tumor virus promoter (MMTV) and the MMTV-Erbb2 model which expresses MMTV-driven erythroblastic leukemia viral oncogene homolog 2 (Erbb2, HER2/Neu) and frequently acquires p53 mutations. We found that loss of either one or two Rlip alleles had a suppressive effect on carcinogenesis in Erbb2 over-expressing mice. Interestingly, Rlip deficiency did not affect tumor growth but significantly reduced the lung metastatic burden of breast cancer in the viral PyVT model, which does not depend on either Ras or loss of p53. Furthermore, spontaneous tumors of MMTV-PyVT/Rlip+/+ mice showed no regression following Rlip knockdown. Finally, mice lacking one or both Rlip alleles differentially expressed markers for apoptotic signaling, proliferation, angiogenesis, and cell cycling in PyVT and Erbb2 breast tumors. Our results support the efficacy of Rlip depletion in suppressing p53 inactivated cancers, and our findings may yield novel methods for prevention or treatment of cancer in patients with HER2 mutations or tumor HER2 expression.